Regain Lifecare Profile
Key Indicators
- Authorised Capital ₹ 6.50 M
as on 24-10-2024
- Paid Up Capital ₹ 6.50 M
as on 24-10-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.40 Cr
as on 24-10-2024
- Satisfied Charges ₹ 8.50 M
as on 24-10-2024
- Revenue -27.93%
(FY 2023)
- Profit -40.83%
(FY 2023)
- Ebitda -183.52%
(FY 2023)
- Net Worth 10.61%
(FY 2023)
- Total Assets -44.47%
(FY 2023)
About Regain Lifecare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.50 M and a paid-up capital of Rs 6.50 M.
The company currently has active open charges totaling ₹3.40 Cr. The company has closed loans amounting to ₹8.50 M, as per Ministry of Corporate Affairs (MCA) records.
Mohit Bhatia, Sumit Bhatia, and Sushant Bhatia serve as directors at the Company.
- CIN/LLPIN
U74999HR2017PLC069403
- Company No.
069403
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 Jun 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Hisar, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Regain Lifecare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohit Bhatia  | Director | 17-Jan-2024 | Current |
| Sumit Bhatia | Director | 07-Jun-2017 | Current |
| Sushant Bhatia | Director | 10-Jan-2020 | Current |
Financial Performance of Regain Lifecare.
Regain Lifecare Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 27.93% decrease. The company also saw a substantial fall in profitability, with a 40.83% decrease in profit. The company's net worth Soared by an impressive increase of 10.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Regain Lifecare?
In 2023, Regain Lifecare had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Roche Chem India Private LimitedActive 15 years 8 months
Mohit Bhatia and Sumit Bhatia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 30 May 2024 | ₹3.40 Cr | Open |
Hdfc Bank Limited Creation Date: 18 Jul 2020 | ₹8.50 M | Satisfied |
How Many Employees Work at Regain Lifecare?
Unlock and access historical data on people associated with Regain Lifecare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Regain Lifecare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regain Lifecare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
